|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.17 USD | +2.38% |
|
+1.63% | +16.97% |
| 07-21 | Danaher's revenue outlook cut, biotech miss overshadow profit forecast lift | RE |
| 07-15 | TD Cowen Adjusts Price Target on Revvity to $130 From $120, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 12.33B | |||||
| 196B | |||||
| 126B | |||||
| 120B | |||||
| 63.87B | |||||
| 48.58B |
- Stock Market
- Stocks
- RVTY Stock
- Charts Revvity, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
